These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 83211)

  • 1. Schizophrenia in a North Swedish geographical isolate, 1900--1977. Epidemiology, genetics and biochemistry.
    Böök JA; Wetterberg L; Modrzewska K
    Clin Genet; 1978 Dec; 14(6):373-94. PubMed ID: 83211
    [No Abstract]   [Full Text] [Related]  

  • 2. Dopamine-beta-hydroxylase, monoamine oxidase, and schizophrenia.
    DeLisi LE; Wise CD; Potkin SG; Zalcman S; Phelps BH; Lovenberg W; Wyatt RJ
    Biol Psychiatry; 1980 Dec; 15(6):895-907. PubMed ID: 7459411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolactin levels in schizophrenia: relation to platelet monoamine oxidase, plasma amine oxidase, plasma dopamine-beta-hydroxylase, and erythrocyte catechol-O-methyltransferase activity.
    Baron M; Levitt M; Asnis L; Fein M
    Biol Psychiatry; 1983 May; 18(5):579-82. PubMed ID: 6860731
    [No Abstract]   [Full Text] [Related]  

  • 4. Plasma dopamine beta-hydroxylase activity in a North Swedish isolate with a high frequency of schizophrenia.
    Ross SB; Böök JA; Wetterberg L
    Clin Genet; 1981 May; 19(5):415-7. PubMed ID: 7296932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet monoamine oxidase, plasma dopamine-beta-hydroxylase and attention in a "biochemical high risk" sample.
    Buchsbaum MS; Murphy DL; Coursey RD; Lake CR; Zeigler MG
    J Psychiatr Res; 1978; 14(1-4):215-24. PubMed ID: 722628
    [No Abstract]   [Full Text] [Related]  

  • 6. Platelet monoamine oxidase activity in schizophrenic families - kinetic aspects.
    Koide Y; Sääf J; Wahlund LO; Roos SB; Wetterberg L
    Clin Genet; 1981 May; 19(5):405-9. PubMed ID: 7296931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurotransmitter-related enzymes in the major psychiatric disorders: II. MAO and DBH in schizophrenia.
    Wyatt RJ; Murphy DL
    Res Publ Assoc Res Nerv Ment Dis; 1975; 54():289-97. PubMed ID: 769116
    [No Abstract]   [Full Text] [Related]  

  • 8. Platelet monoamine oxidase in a pedigree with schizophrenia: an interlaboratory project.
    Ask AL; Böök JA; Heyden T; Ross SB; Unge C; Wetterberg L; Eiduson S; Kobayashi K
    Clin Genet; 1979 Apr; 15(4):289-99. PubMed ID: 436326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationships between platelet and plasma monoamine oxidase, plasma dopamine-beta-hydroxylase, and urinary 3-methoxy-4-hydroxy phenylglycol.
    Belmaker R; Beckmann H; Goodwin F; Murphy D; Pollin W; Buchsbaum M; Wyatt R; Ciaranello P; Lamrecht F
    Life Sci; 1975 Jan; 16(2):273-80. PubMed ID: 1110604
    [No Abstract]   [Full Text] [Related]  

  • 10. [Determination of dopamine-beta-hydroxylase (DBH) and monoamine oxidase (MAO) activities in platelets and plasma in schizophrenic, maniac-depressive and neurotic patients].
    Xavier Vieira R; Azevedo M; Polónio P; Manso C
    Acta Med Port; 1986; 7(1):45-8. PubMed ID: 3728081
    [No Abstract]   [Full Text] [Related]  

  • 11. Platelet monoamine oxidase and serum dopamine-beta-hydroxylase activities in psychotic patients.
    Zizolfi S; Famiglietti LA; Del Vecchio M; Kemali D
    Acta Neurol (Napoli); 1979 Apr; 1(2):142-9. PubMed ID: 474224
    [No Abstract]   [Full Text] [Related]  

  • 12. Platelet monoamine oxidase and plasma dopamine beta-hydroxylase in tardive dyskinesia.
    Jeste DV; Phelps B; Wagner RL; Wise CD; Wyatt RJ
    Lancet; 1979 Oct; 2(8147):850-1. PubMed ID: 90943
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison of MAO, D beta H, and COMT activities in chronic schizophrenics selected on the basis of nailfold capillary pattern.
    Dunlop SR; Sattin A; Shea P; Hendrie HC
    Acta Psychiatr Scand; 1981 Nov; 64(5):409-14. PubMed ID: 7347105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A biochemical study of tardive dyskinesia in young male patients.
    Jeste DV; DeLisi LE; Zalcman S; Wise CD; Phelps BH; Rosenblatt JE; Potkin SG; Bridge TP; Wyatt RJ
    Psychiatry Res; 1981 Jun; 4(3):327-31. PubMed ID: 6115438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic studies of CSF monoamine metabolites.
    Sedvall G; Iselius L; Nybäck H; Oreland L; Oxenstierna G; Ross SB; Wiesel FA
    Adv Biochem Psychopharmacol; 1984; 39():79-85. PubMed ID: 6205565
    [No Abstract]   [Full Text] [Related]  

  • 16. Plasma dopamine-beta-hydroxylase and platelet monoamine oxidase in attention deficit disorder and conduct disorder.
    Bowden CL; Deutsch CK; Swanson JM
    J Am Acad Child Adolesc Psychiatry; 1988 Mar; 27(2):171-4. PubMed ID: 3360718
    [No Abstract]   [Full Text] [Related]  

  • 17. Schizophrenia and malignant neoplasms in a North Swedish population.
    Modrzewska K; Böök JA
    Lancet; 1979 Feb; 1(8110):275-6. PubMed ID: 84932
    [No Abstract]   [Full Text] [Related]  

  • 18. Reduced monoamine oxidase activity in platelets: a possible genetic marker for vulnerability to schizophrenia.
    Wyatt RJ; Murphy DL; Belmaker R; Cohen S; Donnelly CH; Pollin W
    Science; 1973 Mar; 179(4076):916-8. PubMed ID: 4687789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurotransmitter-related enzymes in the major psychiatric disorders: I. Catechol-O-methyl transferase, monoamine oxidase in the affective disorders, and factors affecting some behaviorally correlated enzyme activities.
    Murphy DL; Wyatt RJ
    Res Publ Assoc Res Nerv Ment Dis; 1975; 54():277-88. PubMed ID: 769115
    [No Abstract]   [Full Text] [Related]  

  • 20. [Preliminary study on platelet monoamine oxidase in schizophrenic patients].
    Huang MS
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1980 Apr; 13(4):193-6. PubMed ID: 7261730
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.